| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/20/2010 | CN100581570C Traditional Chinese medicine decoction |
| 01/20/2010 | CN100581555C Viable prebiotics bacteria microcapsule preparations for livestock and method for preparing the same |
| 01/20/2010 | CN100581548C Citric acid Mosabily oral liquid |
| 01/20/2010 | CN100581534C Galangal rhizome extract preparation process |
| 01/20/2010 | CN100581390C Soup material for Hot-pot |
| 01/20/2010 | CN100581379C Disease-preventing liver-protecting preparation for river crab, and its preparing method |
| 01/19/2010 | US7649097 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 01/19/2010 | US7649095 Piperidine derivatives and agent comprising the derivative as active ingredient |
| 01/19/2010 | US7649000 (2'S,2''R)-4-(2'-(2''-amino-3''-(4'''-ethoxyphenyl)propanoylamino)-3'-phenylpropanoyl-amino)piperidine- 1-carboxamidine; inflammatory bowel disease, arthritis, inflammation, septic shock, hypotension, cancer, adult respiratory distress syndrome, disseminated intravascular coagulation |
| 01/19/2010 | US7648988 6-Chloro-2-piperazino-4-pyrrolidinopteridine derivatives; brain, nervous system, respiratory system, gastrointestinal, and psychological disorders; arthritis, antiasthmatics, cancer, leukemia, pain; Crohn's, Alzheimer's, and Parkinson's disease; multiple sclerosis; joint, eye and skin disorders |
| 01/19/2010 | US7648702 Suitable for long-term storage of polypeptides containing an Fc domain of an immunoglobulin; containing polypeptide with an aggregation inhibitor selected from the group consisting of L-arginine and L-cysteine. |
| 01/19/2010 | CA2420026C 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 01/19/2010 | CA2392361C Gastroretentive controlled release pharmaceutical dosage forms |
| 01/19/2010 | CA2373093C Methods and compounds for inhibiting amyloid deposits |
| 01/19/2010 | CA2368097C Amide derivatives of 3,4-dihydroquinazolinone compounds useful as cytokine inhibitors |
| 01/14/2010 | WO2010005958A2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/14/2010 | WO2010005868A2 A vaccine for porcine post-weaning diarrhea caused by enterotoxigenic escherichia coli |
| 01/14/2010 | WO2010005836A2 Use of rifalazil to treat colonic disorders |
| 01/14/2010 | WO2010005765A1 Method of treatment and pharmaceutical compositions |
| 01/14/2010 | WO2010005580A2 Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 01/14/2010 | WO2010005565A2 Method of treating glycogen storage disease |
| 01/14/2010 | WO2010005338A1 Therapeutic and prophylactic formulation for oral care |
| 01/14/2010 | WO2010005047A1 Intestinal environment-improving agent |
| 01/14/2010 | WO2010003805A1 Novel therapeutic use of a pharmaceutical composition for the reduction of the number of aberrant crypt foci and for the prevention of colon cancer |
| 01/14/2010 | WO2008133709A3 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production |
| 01/14/2010 | US20100010061 Cb1 receptor modulators |
| 01/14/2010 | US20100010053 3-[7-(5-{3-Chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-yl]propanoic acid; multiple sclerosis, autoimmune diseases, chronic inflammatory disorders, asthma, inflammatory neuropathies, arthritis, transplantation, Crohn's disease, ulcerative colitis, lupus erythematosis, psoriasis |
| 01/14/2010 | US20100010047 Isotopically substituted proton pump inhibitors |
| 01/14/2010 | US20100010042 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 01/14/2010 | US20100010034 Crth2 antagonists |
| 01/14/2010 | US20100010004 Inhibitors of histone deacetylase |
| 01/14/2010 | US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 01/14/2010 | US20100009947 2-Methylene-19,26-Dinor-(20S,22E,25R)-Vitamin D Analogs |
| 01/14/2010 | US20100009941 2-Methylene-20(21)-Dehydro-19-Nor-Vitamin D Analogs |
| 01/14/2010 | US20100009940 2-Methylene-(20E)-20(22)-Dehydro-19-Nor-Vitamin D Analogs |
| 01/14/2010 | US20100009907 Glucagon-Like Peptides and Uses Thereof |
| 01/14/2010 | US20100009901 Mineral Amino Acid Polysaccharide Complex |
| 01/14/2010 | US20100009003 Pharmaceutical preparation to be dispersed before administration |
| 01/14/2010 | US20100008936 IL-16 antagonist peptides and DNA encoding the peptides |
| 01/14/2010 | US20100008924 Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |
| 01/14/2010 | US20100008916 Inhibit inflammation for long periods without accompanying serious side effects in the drug therapy to patients with inflammatory bowel syndrome |
| 01/14/2010 | US20100008869 Method for preventing coloration of catechins and dentifrice composition |
| 01/14/2010 | US20100008866 Cis-cyclohexyl substituted pyrimidinone derivatives |
| 01/14/2010 | CA2767331A1 Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 01/14/2010 | CA2743975A1 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/14/2010 | CA2730274A1 Use of rifalazil to treat colonic disorders |
| 01/14/2010 | CA2730085A1 Functional micelles for hard tissue targeted delivery of chemicals |
| 01/13/2010 | EP2143719A1 Pharmaceutical composition, food or beverage capable of enhancing sympathetic nerve activity |
| 01/13/2010 | EP2143714A1 Tetrahydroisoquinoline compound |
| 01/13/2010 | EP2143444A1 Compositions for inhibition of anglogenesis |
| 01/13/2010 | EP2143430A1 Drug for preventing and/or treating fatty liver or nonalcoholic fatty liver disease |
| 01/13/2010 | EP2143427A1 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions |
| 01/13/2010 | EP2143424A1 Oral pharmaceutical preparation for colon-specific delivery |
| 01/13/2010 | EP2142531A1 Benzimidazole cannabinoid agonists |
| 01/13/2010 | EP2142200A1 Homeopathy-based formulation |
| 01/13/2010 | EP1465886B1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/13/2010 | EP1406910B1 Preparation methods of derivatives of bisphosphonates |
| 01/13/2010 | EP1144388B1 Acyl derivatives which treat vla-4 related disorders |
| 01/13/2010 | CN101624391A Thiophene derivatives as antiviral agents for flavivirus infection |
| 01/13/2010 | CN100580080C Corona-virus-like particles comprising functionally deleted genomes |
| 01/13/2010 | CN100579998C Oral-use polymer and oral-use composition |
| 01/13/2010 | CN100579987C Liver target fusion protein with siRNA guiding effect |
| 01/13/2010 | CN100579979C 7-phenylpyrazolopyridine compounds |
| 01/13/2010 | CN100579606C Use of whey permeate for the treatment of metabolic syndrome |
| 01/13/2010 | CN100579571C Car sickness preventing and treating beverage |
| 01/13/2010 | CN100579569C Oral Chinese medicine composition for treating liver cirrhosis |
| 01/13/2010 | CN100579562C Oral Chinese medicine composition for treating constipation |
| 01/13/2010 | CN100579559C Oral Chinese-medicinal composition for treating bromopnea |
| 01/13/2010 | CN100579558C Quality control method of particles for treating cardio-cerebral vascular diseases |
| 01/13/2010 | CN100579544C Chinese medicament preparation for treating cholecystitis and gall-stone as well as preparation method thereof |
| 01/13/2010 | CN100579529C Alprostadil freeze-dried emulsion and its preparation method |
| 01/13/2010 | CN100579524C Method of preparing simvastatin sustained-release microsphere carried series |
| 01/13/2010 | CN100579520C Slimming appetising capsule containing natural capsicine for promoting blood circulation and reducing blood fat |
| 01/13/2010 | CN100579518C Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 01/13/2010 | CN100579515C Chewing tablet of malt and preparation method thereof |
| 01/13/2010 | CN100579508C Oral-cleaning orally disintegrating tablet and preparing technique thereof |
| 01/13/2010 | CN100579393C Poria-cocos eight-treasures noodles and preparing method |
| 01/13/2010 | CN100579386C Amber aroma health-care tea |
| 01/12/2010 | US7645864 N-demethyl-N-isopropyl-12-methoxy-11-oxo-8,9-anhydroerythromyc in A-6,9-hemiacetal fumarate; treating with ethyl acetate; reduced content of residual solvent and high suitability for formulation |
| 01/12/2010 | US7645797 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal |
| 01/12/2010 | US7645779 Linked biaryl compounds |
| 01/12/2010 | US7645774 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis |
| 01/12/2010 | US7645754 Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and use |
| 01/12/2010 | US7645734 Compositions and methods for treating and preventing heart tissue degeneration and uses thereof |
| 01/12/2010 | US7645610 Hepatocyte precursor cell lines |
| 01/12/2010 | CA2483678C 6-11 bicyclic ketolide derivatives |
| 01/12/2010 | CA2481461C Derivatives of n-[phenyl(piperidin-2-yl) methyl] benzamide, the preparation method thereof and application of same in therapeutics |
| 01/12/2010 | CA2461946C Combinations for the treatment of immunoinflammatory disorders |
| 01/12/2010 | CA2439831C Polymorphic and other crystalline forms of cis-ftc |
| 01/12/2010 | CA2438143C Modified proteins, designer toxins, and methods of making thereof |
| 01/12/2010 | CA2409664C Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione |
| 01/12/2010 | CA2407838C Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 01/12/2010 | CA2403514C 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors |
| 01/12/2010 | CA2399818C Preventive and therapeutic medicament for gastroesophageal reflux disease |
| 01/12/2010 | CA2306428C 3-oxo-2(h)-1,2,4 - triazine derivatives as ligands of 5ht1a receptors |
| 01/07/2010 | WO2010002244A1 Nutritional composition for infants delivered via caesarean section |
| 01/07/2010 | WO2010002241A1 Nutritional composition for infants delivered via caesarean section |
| 01/07/2010 | WO2010002010A1 Novel spirochromanone carboxylic acids |
| 01/07/2010 | WO2010001990A1 Tetracyclic compound |
| 01/07/2010 | WO2010001930A1 Solid preparation for internal application |